Skip to content

CNTN

Canton Strategic Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.69
−0.29%
Ask drillr

Year over year

Reported trailing growth

Revenue
—
EBITDA
—
EBIT
—
EPS
+73.9%
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
+300.0%
EBITDA
—
EPS
—

Three-year CAGR

Revenue
—
EBITDA
-64.3%
EBIT
-61.7%
Net income
—
EPS
+88.1%
Free cash flow
—

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026